cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.
cAMPfield Therapeutics has raised $180.0M in total funding. The most recent round was Series A. The last funding was announced in May 2026.
cAMPfield Therapeutics's investors include RA Capital Management, Novo Holdings, Venrock, Abingworth, Frazier Life Sciences.
cAMPfield Therapeutics is headquartered in San Diego, United States.
cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.
cAMPfield Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"cAMPfield Therapeutics — Funding & Investors." VCBacked, May 20, 2026, https://www.vcbacked.co/company/campfield-therapeutics. Accessed July 20, 2026.
VCBacked. (2026). cAMPfield Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/campfield-therapeutics
{{cite web |title=cAMPfield Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/campfield-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated